Perspective Therapeutics CATX
NYSE CATX
$2.73 -0.02 (-0.73%)
As of: Oct 1, 2026 · 3:59 PM EDT

Perspective Therapeutics (CATX) Return on Assets [ROA] (2011 - 2026)

Updated

Perspective Therapeutics (CATX) posted Return on Assets [ROA] of -29.25% for Q2 2026, up 1.53 percentage points from -30.78% a year earlier and up 3.93 percentage points from the prior quarter.

Analysis

Perspective Therapeutics (CATX) Return on Assets [ROA] (2011 - 2026) Analysis & Trends

For FY2025, Perspective Therapeutics' Return on Assets [ROA] came in at -34.35%, up 2.73 percentage points from FY2024.

  • Annual Return on Assets [ROA] shows a five-year change of +3.69 percentage points (FY2020 to FY2025).
  • In prior years, Perspective Therapeutics' Return on Assets [ROA] was -37.07% in FY2024 (+22.56 pp), -59.63% in FY2023 (-42.07 pp), -17.56% in FY2022 and -8.56% in FY2021 (+29.47 pp).
  • The Q2 2026 figure stands as the highest quarterly Return on Assets [ROA] since Q1 2025.
  • On a year-over-year basis, Return on Assets [ROA] increased in four of the last eight quarters, with an average year-over-year change of -3.00 percentage points.
  • The strongest year-over-year quarter for Return on Assets [ROA] in the past five years was Q4 2024, with a gain of 22.41 percentage points; the weakest was Q4 2023, with a drop of 26.79 percentage points.
  • According to Business Quant data, Return on Assets [ROA] for the three prior quarters was -33.18% (Q1 2026), -37.18% (Q4 2025) and -36.12% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 10.47%
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 4.65%
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 2.45%
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 28.37%
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 9.10%
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 9.29%
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -6.13%
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 2.14%
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 16.34%
10 Perspective Therapeutics 312.60 Mn 312.60 Mn - -29.25%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -29.25%
Mar 31, 2026 -33.18%
Dec 31, 2025 -37.18%
Sep 30, 2025 -36.12%
Jun 30, 2025 -30.78%
Mar 31, 2025 -26.17%
Dec 31, 2024 -22.23%
Sep 30, 2024 -16.17%
Jun 30, 2024 -17.49%
Mar 31, 2024 -30.82%
Dec 31, 2023 -44.63%
Sep 30, 2023 -18.79%
Jun 30, 2023 -12.42%
Mar 31, 2023 -6.85%
Dec 31, 2022 -12.16%
Sep 30, 2022 -14.33%
Jun 30, 2022 -11.14%
Mar 31, 2022 -9.38%
Dec 31, 2021 -8.32%
Sep 30, 2021 -7.07%
API Access

Perspective Therapeutics Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=CATX&period=max&api_key=YOUR_API_KEY